Background Image
Table of Contents Table of Contents
Previous Page  47 / 124 Next Page
Information
Show Menu
Previous Page 47 / 124 Next Page
Page Background

47

Food and Drug Administration

c. Train seeded regulatory personnel

In collaboration with the Center for Drug Evaluation (CDE) and the 37 seeded regulatory

personnel, TFDA began on-site consultation in the Hsinchu Biomedical Science

Park and the Lujhu Kaohsiung Biomedical Park to help industry overcome regulatory

obstacles.

Section 2 Medical Devices Source Control

Status

,UZ\YPUN Z\Z[HPULK Z[HISL WYVK\J[PVU HUK THUHNLTLU[ [V TLL[ [OL ULLKZ VY ZWLJPÄJH[PVUZ VM [OL

original design is an important quality assurance for medical devices. The implementation of quality

management for medical device manufacturing is an effective measure for source control.

Policy and Outcome

1. The Internationalized GMP Regulation for Medical Devices

;OL HSPNUTLU[ VM .47 ^P[O NSVIHS YLN\SH[VY` YLX\PYLTLU[Z

6U 4HYJO

[OL

7OHYTHJL\[PJHS .VVK 4HU\MHJ[\YPUN 7YHJ[PJL 9LN\SH[PVUZ

was

announced and the

:[HUKHYKZ MVY 4LKPJHTLU[ -HJ[VY` ,Z[HISPZOTLU[Z

was amended.

The 2003 version of ISO 13485 was thereby adopted for implementation. It was set forth

that

Class 1 medical devices that are non-sterile or without a measuring function

and

medical devices for use in clinical trials

T\Z[ JVTWS` ^P[O [OL .47 YLX\PYLTLU[Z ;OPZ

M\SS` PUJVYWVYH[LK ZLSM JVTWSPHUJL VM TLKPJHS KL]PJL .47 HUK WYVTV[LK [OL X\HSP[` VM

domestic manufacturing factories to a higher level.

(2) Signing of Technical Cooperation Programme between authorized auditing organizations

of Taiwan and European Union

In 2013, the signing of

Technical Cooperation Programme, TCP II

was completed

between 4 TFDA authorized auditing organizations and 11 EU notified bodies. Both

sides would recognize the mutual acceptance of audit reports, which effectively reduced

duplicate inspections of the quality system for 18 manufacturers and enhanced the pace

of medical device entrance into the global market.

2. Systemic Oversight of Authorized Auditing Organizations

*\YYLU[S` [OLYL HYL 9 6 * TLKPJHS KL]PJL .47 H\[OVYPaLK H\KP[PUN VYNHUPaH[PVUZ

PUJS\KPUN *LU[LY MVY 4LHZ\YLTLU[ :[HUKHYKZ VM 0UK\Z[YPHS ;LJOUVSVN` 9LZLHYJO 0UZ[P[\[L

,SLJ[YVUPJZ ;LZ[PUN *LU[LY 4L[HS 0UK\Z[YPLZ 9LZLHYJO +L]LSVWTLU[ *LU[YL HUK

Plastics Industry Development Center. In order to facilitate the global alignment of medical

KL]PJL .47 H\KP[PUN Z`Z[LT ;-+( JVUK\J[LK

headquarter assessment

and

witness

assessment

on authorized auditing organizations to ensure the quality of audit.